| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 2.196 | 0 | 0 | 21.092 | 70.703 | 138.705 | 116.559 | 165.776 |
| Total Income - EUR | - | - | 2.196 | 0 | 0 | 21.179 | 70.703 | 138.717 | 116.559 | 165.776 |
| Total Expenses - EUR | - | - | 1.999 | 0 | 0 | 20.234 | 63.413 | 135.932 | 110.233 | 164.697 |
| Gross Profit/Loss - EUR | - | - | 197 | 0 | 0 | 945 | 7.290 | 2.785 | 6.326 | 1.079 |
| Net Profit/Loss - EUR | - | - | 131 | 0 | 0 | 317 | 5.723 | 795 | 5.161 | 906 |
| Employees | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 |
Check the financial reports for the company - Lima Inject Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 1.302 | 3.183 | 8.778 | 7.144 | 5.505 |
| Current Assets | - | - | 439 | 431 | 633 | 12.082 | 32.689 | 17.609 | 24.586 | 34.609 |
| Inventories | - | - | 274 | 269 | 457 | 7.884 | 21.452 | 12.659 | 21.054 | 22.005 |
| Receivables | - | - | 0 | 0 | 0 | 2.458 | 11.013 | 2.719 | 3.121 | 9.669 |
| Cash | - | - | 165 | 162 | 176 | 1.740 | 224 | 2.230 | 411 | 2.936 |
| Shareholders Funds | - | - | 174 | 171 | 168 | 523 | 6.195 | 7.008 | 12.148 | 12.986 |
| Social Capital | - | - | 44 | 43 | 42 | 83 | 40 | 41 | 40 | 40 |
| Debts | - | - | 264 | 260 | 465 | 12.861 | 29.678 | 19.378 | 19.582 | 27.128 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4520 - 4520" | |||||||||
| CAEN Financial Year |
4520
|
|||||||||
Comments - Lima Inject Srl